Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Platelet-rich plasma boosts hair growth by enhancing autophagy.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Keratin-associated proteins may have roles in various mouse tissues, not just hair.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

TSPO might help treat anxiety and depression.

Mutations in the AP1B1 gene cause a new syndrome with skin, hearing, and developmental issues.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

A mouse model was created to study hair loss similar to humans.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

A specific gene mutation causes complete hair loss without other health issues.

ARHGEF3 is essential for proper hair follicle development in mice.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

Androgen receptor differences may contribute to hair loss in AGA patients.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Gremlin proteins help regulate hair growth by balancing signals in hair follicles.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Gene differences found in hair follicles linked to male baldness.

HR protein causes abnormal hair cycles by increasing Tgf-β2 and reducing miR-31.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

A Japanese patient with IFAP syndrome had a severe MBTPS2 gene mutation but showed milder symptoms than previously observed cases.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

YAP1 helps fat cell formation by influencing the Hippo pathway.